Benefit of Cisplatin With Definitive Radiotherapy in Older Women With Cervical Cancer.
CONCLUSIONS: Administration of cisplatin with definitive RT in women aged ≥65 years was associated with a significant benefit in the incidence of death attributable to cervical cancer, despite competing risks for mortality in an older population. Receiving at least 5 cycles of weekly cisplatin was required for benefit.
PMID: 31390586 [PubMed - in process]
Source: Journal of the National Comprehensive Cancer Network : JNCCN - Category: Cancer & Oncology Tags: J Natl Compr Canc Netw Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Cervical Cancer | Chronic Kidney Disease | Clinical Trials | Databases & Libraries | External Beam Therapy | Medicare | Urology & Nephrology | Women